Weight gain and metabolic issues of medicines used for bipolar disorder - PubMed (original) (raw)
Review
Weight gain and metabolic issues of medicines used for bipolar disorder
Andrea Fagiolini et al. Curr Psychiatry Rep. 2007 Dec.
Abstract
Patients with bipolar disorder are at high risk of gaining weight and developing metabolic illnesses, and pharmacologic treatment for the disorder may significantly increase this risk. This paper reviews the literature on the metabolic consequences of the medications used in bipolar disorder and describes the possible strategies to prevent, monitor, and treat the common metabolic illnesses that patients with bipolar disorder may develop during treatment.
References
- Psychopharmacology (Berl). 2003 Apr;166(4):391-9 - PubMed
- J Clin Psychiatry. 1999 Apr;60(4):249-55 - PubMed
- Clin Ther. 2002 Oct;24(10):1576-84 - PubMed
- J Clin Pharm Ther. 2007 Apr;32(2):197-8 - PubMed
- J Clin Psychopharmacol. 2004 Jun;24(3):322-34 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical